Posttreatment Imaging in Patients with Head and Neck Cancer without Clinical Evidence of Recurrence: Should Surveillance Imaging Extend Beyond 6 Months?

BACKGROUND AND PURPOSE: Early detection of residual or recurrent disease is important for effective salvage treatment in patients with head and neck cancer. Current National Comprehensive Cancer Network guidelines do not recommend standard surveillance imaging beyond 6 months unless there are worris...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:AJNR Am J Neuroradiol
Hlavní autoři: Gore, A., Baugnon, K., Beitler, J., Saba, N.F., Patel, M.R., Wu, X., Boyce, B.J., Aiken, A.H.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Neuroradiology 2020
Témata:
Head & Neck
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7357658/
https://ncbi.nlm.nih.gov/pubmed/32554418
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3174/ajnr.A6614
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky